Consistent with prior surveys of health-care professionals, most respondents said they possessed “low knowledge and competence” with respect to medical cannabis use.
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
“After years of advocacy, collaboration, and grassroots organizing, we are thrilled to see cannabis legalization become a reality in our state,” Delaware NORML’s Executive Director, Laura Sharer said.
“[Our study] shows that the majority of participants reported an improvement in their subjective sleep symptoms since commencing medical cannabis,” investigators concluded.
“The results demonstrate that all terpenes, when tested individually, activate CB1 receptors, at about 10-50 percent of the activation by THC alone,” researchers affirmed.
On a scale of zero (totally ineffective) to 10 (totally effective), 69 percent of users rated the effectiveness of cannabis as 7 or higher at relieving pelvic pain.
“Collectively, these in vitro and in vivo findings suggest that CBD exerts cell-specific effects which can be exploited to enhance bone metabolism,” authors concluded.
“The lack of accurate reporting can have impacts on medical patients controlling [their] dosage, recreational consumers expecting an effect aligned with price, and trust in the industry as a whole.”
“There was no significant association between any measure of cannabis use at baseline and either transition to psychosis, the persistence of symptoms, or functional outcomes,” researchers reported.